Dive into the archives.
- Generic Betaseron Wins FDA Approval
By Eva von Schaper
Aug. 17 (Bloomberg) — Novartis AG won U.S. Food and Drug Administration approval to sell its Extavia multiple sclerosis treatment, its brand of Bayer AG’s Betaseron.
Extavia, a form of interferon beta-1b, can be used in patients with early and relapsing forms of multiple sclerosis, Basel, Switzerland-based Novartis said in a statement today.
Selling [...]
- Exercise Your Brain: Online Game Launched for PWMS
Article Date: 16 Jul 2009 – 3:00 PDT
The MS Technology Collaborative has created a new way for people living with multiple sclerosis (MS) to exercise their brain power. The Collaborative, an alliance of Bayer HealthCare Pharmaceuticals, Microsoft, and the National Multiple Sclerosis Society, today announced the launch of MyBrainGames, a free suite of online games [...]
- Take Betaseron, Get Paid?
Betaplus Offers Copay Refund
March 4, 2009
As part of its Betaplus patient support program, Bayer will refund a single copay for those who take Betaseron for 11 consecutive months.
Under the new benefit, people who send in their prescription receipts for Betaseron will be refunded the copay for their 11th month of use of the drug, up [...]
